APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain-relieving API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pain-relieving API Industry Growth and Trends Forecast to 2032

31 December 2025102 pages

Choose your research edition.

Industry ResearchPain-relieving API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain-relieving API Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pain-relieving API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain-relieving API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain-relieving API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pain-relieving API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain-relieving API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pain-relieving API include Xinhua Pharmaceutical, Sanofi, Biocause Heilen, SOLARA, SI Group, Noramco, IOLCP, Biocause and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pain-relieving API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pain-relieving API market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pain-relieving API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pain-relieving API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pain-relieving API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pain-relieving API Market by Company

Xinhua Pharmaceutical

Sanofi

Biocause Heilen

SOLARA

SI Group

Noramco

IOLCP

Biocause

BASF

Aspen API The Netherlands

Pain-relieving API Segment by Type

Opiate

Non-Opiate

Pain-relieving API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Pain-relieving API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain-relieving API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain-relieving API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain-relieving API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pain-relieving API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pain-relieving API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Opiate Table 2. Major Company of Non-Opiate Table 3. Global Pain-relieving API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 5. Global Pain-relieving API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pain-relieving API Sales Market Share in Value by Type (2021-2026) Table 8. Global Pain-relieving API Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 10. Global Pain-relieving API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pain-relieving API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pain-relieving API Sales Market Share in Value by Type (2027-2032) Table 13. Global Pain-relieving API Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 15. North America Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 17. Europe Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 21. Latin America Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Pain-relieving API Sales by Type (2021-2026) & (US$ Million) Table 24. Pain-relieving API Industry Trends Table 25. Pain-relieving API Industry Drivers Table 26. Pain-relieving API Industry Opportunities and Challenges Table 27. Pain-relieving API Industry Restraints Table 28. Global Pain-relieving API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pain-relieving API Revenue Market Share by Company (2021-2026) Table 30. Global Pain-relieving API Sales by Company (2021-2026) & (K Units) Table 31. Global Pain-relieving API Sales Share by Company (2021-2026) Table 32. Global Pain-relieving API Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pain-relieving API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pain-relieving API Major Company Production Sites and Headquarters Table 35. Global Pain-relieving API Company, Product Type & Application Table 36. Global Pain-relieving API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pain-relieving API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pain-relieving API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pain-relieving API Sales by Region (2021-2026) & (K Units) Table 41. Global Pain-relieving API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pain-relieving API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pain-relieving API Sales Market Share in Value by Region (2021-2026) Table 44. Global Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pain-relieving API Sales by Region (2027-2032) & (K Units) Table 46. Global Pain-relieving API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pain-relieving API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pain-relieving API Sales Market Share in Value by Region (2027-2032) Table 49. Global Pain-relieving API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pain-relieving API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 52. Global Pain-relieving API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pain-relieving API Sales Market Share in Value by Application (2021-2026) Table 55. Global Pain-relieving API Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 57. Global Pain-relieving API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pain-relieving API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pain-relieving API Sales Market Share in Value by Application (2027-2032) Table 60. Global Pain-relieving API Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 62. North America Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 64. Europe Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 68. Latin America Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Pain-relieving API Sales by Application (2021-2026) & (US$ Million) Table 71. Xinhua Pharmaceutical Company Information Table 72. Xinhua Pharmaceutical Business Overview Table 73. Xinhua Pharmaceutical Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Xinhua Pharmaceutical Pain-relieving API Product Portfolio Table 75. Xinhua Pharmaceutical Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Pain-relieving API Product Portfolio Table 80. Sanofi Recent Development Table 81. Biocause Heilen Company Information Table 82. Biocause Heilen Business Overview Table 83. Biocause Heilen Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Biocause Heilen Pain-relieving API Product Portfolio Table 85. Biocause Heilen Recent Development Table 86. SOLARA Company Information Table 87. SOLARA Business Overview Table 88. SOLARA Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. SOLARA Pain-relieving API Product Portfolio Table 90. SOLARA Recent Development Table 91. SI Group Company Information Table 92. SI Group Business Overview Table 93. SI Group Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. SI Group Pain-relieving API Product Portfolio Table 95. SI Group Recent Development Table 96. Noramco Company Information Table 97. Noramco Business Overview Table 98. Noramco Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Noramco Pain-relieving API Product Portfolio Table 100. Noramco Recent Development Table 101. IOLCP Company Information Table 102. IOLCP Business Overview Table 103. IOLCP Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. IOLCP Pain-relieving API Product Portfolio Table 105. IOLCP Recent Development Table 106. Biocause Company Information Table 107. Biocause Business Overview Table 108. Biocause Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Biocause Pain-relieving API Product Portfolio Table 110. Biocause Recent Development Table 111. BASF Company Information Table 112. BASF Business Overview Table 113. BASF Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. BASF Pain-relieving API Product Portfolio Table 115. BASF Recent Development Table 116. Aspen API The Netherlands Company Information Table 117. Aspen API The Netherlands Business Overview Table 118. Aspen API The Netherlands Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Aspen API The Netherlands Pain-relieving API Product Portfolio Table 120. Aspen API The Netherlands Recent Development Table 121. North America Pain-relieving API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 123. North America Pain-relieving API Sales Market Share by Country (2021-2026) Table 124. North America Pain-relieving API Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Pain-relieving API Sales Market Share Forecast by Country (2027-2032) Table 126. North America Pain-relieving API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Pain-relieving API Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Pain-relieving API Market Share by Country (2021-2026) Table 129. North America Pain-relieving API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Pain-relieving API Market Share Forecast by Country (2027-2032) Table 131. Europe Pain-relieving API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 133. Europe Pain-relieving API Sales Market Share by Country (2021-2026) Table 134. Europe Pain-relieving API Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Pain-relieving API Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Pain-relieving API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Pain-relieving API Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Pain-relieving API Market Share by Country (2021-2026) Table 139. Europe Pain-relieving API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Pain-relieving API Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Pain-relieving API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Pain-relieving API Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Pain-relieving API Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Pain-relieving API Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Pain-relieving API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Pain-relieving API Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Pain-relieving API Market Share by Country (2021-2026) Table 149. Asia-Pacific Pain-relieving API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Pain-relieving API Market Share Forecast by Country (2027-2032) Table 151. Latin America Pain-relieving API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 153. Latin America Pain-relieving API Sales Market Share by Country (2021-2026) Table 154. Latin America Pain-relieving API Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Pain-relieving API Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Pain-relieving API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Pain-relieving API Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Pain-relieving API Market Share by Country (2021-2026) Table 159. Latin America Pain-relieving API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Pain-relieving API Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Pain-relieving API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Pain-relieving API Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Pain-relieving API Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Pain-relieving API Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Pain-relieving API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Pain-relieving API Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Pain-relieving API Market Share by Country (2021-2026) Table 169. Middle East and Africa Pain-relieving API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Pain-relieving API Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Pain-relieving API Distributors List Table 174. Pain-relieving API Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Pain-relieving API Image Figure 2. Global Pain-relieving API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain-relieving API Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain-relieving API Sales (2021-2032) & (K Units) Figure 5. Opiate Image Figure 6. Global Opiate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Non-Opiate Image Figure 8. Global Non-Opiate Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Pain-relieving API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pain-relieving API Market Share by Type 2025 VS 2032 Figure 11. North America Pain-relieving API Sales Market Share in Volume by Type in 2025 Figure 12. North America Pain-relieving API Sales Market Share in Value by Type in 2025 Figure 13. Europe Pain-relieving API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pain-relieving API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pain-relieving API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pain-relieving API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pain-relieving API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pain-relieving API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pain-relieving API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pain-relieving API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pain-relieving API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Contract Manufacturing Organizations Image Figure 24. Global Contract Manufacturing Organizations Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmaceutical Companies Image Figure 26. Global Pharmaceutical Companies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Pain-relieving API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pain-relieving API Market Share by Application 2025 VS 2032 Figure 31. North America Pain-relieving API Sales Market Share in Volume by Application in 2025 Figure 32. North America Pain-relieving API Sales Market Share in Value by Application in 2025 Figure 33. Europe Pain-relieving API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pain-relieving API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pain-relieving API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pain-relieving API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pain-relieving API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pain-relieving API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pain-relieving API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pain-relieving API Sales Market Share in Value by Application in 2025 Figure 41. North America Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Pain-relieving API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pain-relieving API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pain-relieving API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Pain-relieving API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pain-relieving API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pain-relieving API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Pain-relieving API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pain-relieving API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pain-relieving API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Pain-relieving API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pain-relieving API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pain-relieving API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pain-relieving API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Pain-relieving API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pain-relieving API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pain-relieving API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pain-relieving API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pain-relieving API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Opiate
  • Non-Opiate
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • Xinhua Pharmaceutical
  • Sanofi
  • Biocause Heilen
  • SOLARA
  • SI Group
  • Noramco
  • IOLCP
  • Biocause
  • BASF
  • Aspen API The Netherlands

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pain-relieving API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pain-relieving API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pain-relieving API Market by Type
  6. 1.3.1 Opiate
  7. 1.3.2 Non-Opiate
  8. 1.4 Global Pain-relieving API Market Size by Type
  9. 1.4.1 Global Pain-relieving API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pain-relieving API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pain-relieving API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pain-relieving API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pain-relieving API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pain-relieving API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pain-relieving API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pain-relieving API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pain-relieving API Industry Trends
  2. 2.2 Pain-relieving API Industry Drivers
  3. 2.3 Pain-relieving API Industry Opportunities and Challenges
  4. 2.4 Pain-relieving API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pain-relieving API Revenue (2021-2026)
  2. 3.2 Global Top Players by Pain-relieving API Sales (2021-2026)
  3. 3.3 Global Top Players by Pain-relieving API Price (2021-2026)
  4. 3.4 Global Pain-relieving API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pain-relieving API Major Company Production Sites & Headquarters
  6. 3.6 Global Pain-relieving API Company, Product Type & Application
  7. 3.7 Global Pain-relieving API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pain-relieving API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pain-relieving API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pain-relieving API Tier 1, Tier 2, and Tier 3
4 Pain-relieving API Regional Status and Outlook
  1. 4.1 Global Pain-relieving API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pain-relieving API Historic Market Size by Region
  3. 4.2.1 Global Pain-relieving API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pain-relieving API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pain-relieving API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pain-relieving API Forecasted Market Size by Region
  7. 4.3.1 Global Pain-relieving API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pain-relieving API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pain-relieving API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pain-relieving API by Application
  1. 5.1 Pain-relieving API Market by Application
  2. 5.1.1 Contract Manufacturing Organizations
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Pain-relieving API Market Size by Application
  6. 5.2.1 Global Pain-relieving API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pain-relieving API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pain-relieving API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pain-relieving API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pain-relieving API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pain-relieving API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pain-relieving API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pain-relieving API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xinhua Pharmaceutical
  2. 6.1.1 Xinhua Pharmaceutical Company Information
  3. 6.1.2 Xinhua Pharmaceutical Business Overview
  4. 6.1.3 Xinhua Pharmaceutical Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xinhua Pharmaceutical Pain-relieving API Product Portfolio
  6. 6.1.5 Xinhua Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pain-relieving API Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Biocause Heilen
  14. 6.3.1 Biocause Heilen Company Information
  15. 6.3.2 Biocause Heilen Business Overview
  16. 6.3.3 Biocause Heilen Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biocause Heilen Pain-relieving API Product Portfolio
  18. 6.3.5 Biocause Heilen Recent Developments
  19. 6.4 SOLARA
  20. 6.4.1 SOLARA Company Information
  21. 6.4.2 SOLARA Business Overview
  22. 6.4.3 SOLARA Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SOLARA Pain-relieving API Product Portfolio
  24. 6.4.5 SOLARA Recent Developments
  25. 6.5 SI Group
  26. 6.5.1 SI Group Company Information
  27. 6.5.2 SI Group Business Overview
  28. 6.5.3 SI Group Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SI Group Pain-relieving API Product Portfolio
  30. 6.5.5 SI Group Recent Developments
  31. 6.6 Noramco
  32. 6.6.1 Noramco Company Information
  33. 6.6.2 Noramco Business Overview
  34. 6.6.3 Noramco Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Noramco Pain-relieving API Product Portfolio
  36. 6.6.5 Noramco Recent Developments
  37. 6.7 IOLCP
  38. 6.7.1 IOLCP Company Information
  39. 6.7.2 IOLCP Business Overview
  40. 6.7.3 IOLCP Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 IOLCP Pain-relieving API Product Portfolio
  42. 6.7.5 IOLCP Recent Developments
  43. 6.8 Biocause
  44. 6.8.1 Biocause Company Information
  45. 6.8.2 Biocause Business Overview
  46. 6.8.3 Biocause Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biocause Pain-relieving API Product Portfolio
  48. 6.8.5 Biocause Recent Developments
  49. 6.9 BASF
  50. 6.9.1 BASF Company Information
  51. 6.9.2 BASF Business Overview
  52. 6.9.3 BASF Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BASF Pain-relieving API Product Portfolio
  54. 6.9.5 BASF Recent Developments
  55. 6.10 Aspen API The Netherlands
  56. 6.10.1 Aspen API The Netherlands Company Information
  57. 6.10.2 Aspen API The Netherlands Business Overview
  58. 6.10.3 Aspen API The Netherlands Pain-relieving API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Aspen API The Netherlands Pain-relieving API Product Portfolio
  60. 6.10.5 Aspen API The Netherlands Recent Developments
7 North America by Country
  1. 7.1 North America Pain-relieving API Sales by Country
  2. 7.1.1 North America Pain-relieving API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pain-relieving API Sales by Country (2021-2026)
  4. 7.1.3 North America Pain-relieving API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pain-relieving API Market Size by Country
  6. 7.2.1 North America Pain-relieving API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pain-relieving API Market Size by Country (2021-2026)
  8. 7.2.3 North America Pain-relieving API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pain-relieving API Sales by Country
  2. 8.1.1 Europe Pain-relieving API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pain-relieving API Sales by Country (2021-2026)
  4. 8.1.3 Europe Pain-relieving API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pain-relieving API Market Size by Country
  6. 8.2.1 Europe Pain-relieving API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pain-relieving API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pain-relieving API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pain-relieving API Sales by Country
  2. 9.1.1 Asia-Pacific Pain-relieving API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pain-relieving API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pain-relieving API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pain-relieving API Market Size by Country
  6. 9.2.1 Asia-Pacific Pain-relieving API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pain-relieving API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pain-relieving API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pain-relieving API Sales by Country
  2. 10.1.1 South America Pain-relieving API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pain-relieving API Sales by Country (2021-2026)
  4. 10.1.3 South America Pain-relieving API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pain-relieving API Market Size by Country
  6. 10.2.1 South America Pain-relieving API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pain-relieving API Market Size by Country (2021-2026)
  8. 10.2.3 South America Pain-relieving API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pain-relieving API Sales by Country
  2. 11.1.1 Middle East and Africa Pain-relieving API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pain-relieving API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pain-relieving API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pain-relieving API Market Size by Country
  6. 11.2.1 Middle East and Africa Pain-relieving API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pain-relieving API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pain-relieving API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pain-relieving API Value Chain Analysis
  2. 12.1.1 Pain-relieving API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pain-relieving API Production Mode & Process
  7. 12.2 Pain-relieving API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pain-relieving API Distributors
  10. 12.2.3 Pain-relieving API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst